Abemaciclib in Treating Patients With Advanced, Refractory, and Unresectable Digestive System Neuroendocrine Tumors

Conditions

• Advanced Digestive System Neuroendocrine Neoplasm
• Digestive System Neuroendocrine Tumor
• Foregut Neuroendocrine Tumor
• Hindgut Neuroendocrine Tumor
• Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm
• Metastatic Digestive System Neuroendocrine Neoplasm
• Midgut Neuroendocrine Tumor
• Pancreatic Neuroendocrine Tumor
• Refractory Digestive System Neuroendocrine Neoplasm

Interventions

• DRUG: Abemaciclib

Sponsor

University of Washington

Collaborators

• [object Object]